Hydrochloric Acid → Zantac

HRID 53911

反応式

HRID 53911 の反応式
[CH3:1][N:2]([CH2:4][C:5]1[O:9][C:8]([CH2:10][S:11][CH2:12][CH2:13][NH:14][C:15]([NH:20][CH3:21])=[CH:16][N+:17]([O-:19])=[O:18])=[CH:7][CH:6]=1)[CH3:3].[ClH:22].C1(C)C=CC=CC=1>C(O)(C)C>[CH3:21][NH:20][C:15]([NH:14][CH2:13][CH2:12][S:11][CH2:10][C:8]1[O:9][C:5]([CH2:4][N:2]([CH3:1])[CH3:3])=[CH:6][CH:7]=1)=[CH:16][N+:17]([O-:19])=[O:18].[ClH:22]

参加物

5

反応物 3

HCID 313Hydrochloric AcidHCID 1140TolueneHCID 5039Ranisen

生成物 1

HCID 47909Zantac

試薬・触媒・溶媒 1

HCID 3776Isopropanol溶媒

実験手順

N-[2-[[[5-(Dimethylamino)methyl-2-furanyl]methyl]thio]ethyl]-N'-methyl-2-nitro-1,1-ethenediamine (5 g) was dissolved in isopropanol (40 ml) containing molar equivalent of hydrogen chloride. Toluene (20 ml) was added slowly to the solution. It was further stirred for 1 hr. Form 1 ranitidine hydrochloride crystallized during this period. The product was filtered off, washed with toluene (20 ml) and was dried at 45° C. under vacuum to give Form 1 ranitidine hydrochloride (5.08 g), m.p. 137°-138° C., DSC peak temperature=143.1° C., purity=99.7% (HPLC).

後処理

  1. customForm 1 ranitidine hydrochloride crystallized during this period
  2. filtrationThe product was filtered off
  3. washwashed with toluene (20 ml)
  4. customwas dried at 45° C. under vacuum

出典と根拠

ORDレコード
ord-0841530950d5431c8af5de878923a881
出典データセット
uspto-grants-1997_04
特許番号
US05621120

関連ノート

読み込み中…